Mulmit

Zivo Bioscience, Inc.Zivo Bioscience, Inc.

ZIVO OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-31157,220-13,361,897-13,384,836-4.23
2023-12-3127,650-7,263,012-7,777,184-4.6
2022-12-310-8,731,974-8,745,293

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-04-17STROME MARK E100,000
2026-02-27YALDOO LAITH L1,543
2026-02-12STROME MARK E20,000
2026-02-12STROME MARK E2,000
2026-02-10YALDOO LAITH L2,434
2026-01-26Cornell Alison A11,709
2026-01-26PAYNE JOHN BERNARDPresident and CEO11,709
2026-01-14Maggiore Christopher D.1,766
2026-01-14YALDOO LAITH L1,766
2025-11-28YALDOO LAITH L2,777
2025-10-13STROME MARK E20,259
2025-10-13STROME MARK E2,025

8-K events

FiledItems
2026-03-30Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2025-12-23Officer or director change · Financial statements and exhibits
2025-09-10Regulation FD disclosure · Financial statements and exhibits
2025-08-18Officer or director change
2025-07-14Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2025-06-11Submission of matters to a vote
2025-01-27Unregistered sales of equity securities
2025-01-15Entry into a material agreement · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.